-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Public Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
IQVIA AI Assistant
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions with Apple devices
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Public Health
- Code of Conduct
- Environmental Social Governance
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Meet the IQVIA AI Assistant
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions with Apple devices
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREWORKING AT IQVIA
Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORELIFE AT IQVIA
Careers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
WE’RE HIRING
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSBlog
IQVIA at DIA 2022: DAY 2 Recap
Jun 21, 2022
Closing out another informative day at DIA 2022, we gained many key learnings to help improve health globally, And, IQVIA leadership shared key insights on innovative strategies and scalable solutions the team has leveraged to continue advancing lifesaving therapies for patients in need when the trial landscape grows more complex by the day.
In a time when agility matters most, it is important for trial sponsors and partners in drug development to stay in the know of how to accelerate drug development through effective trial design and execution, using the right mix of expertise, technologies and data-based insights to inform smarter decisions for patients.
Today, IQVIA leadership participated in several discussions to help attendees gain actionable insights for key stages of a clinical trial process:
- During the Innovation Theater presentation, “Delivering Better Outcomes with Connected Intelligence,” IQVIA’s Chief Digital Officer Nagaraja Srivatsan and Murray Aitken, executive director of the IQVIA Institute for Human Data Science, paired up to highlight key findings from research evaluating the pandemic’s impact on clinical development, including:
- How the pandemic affects the adoption and use of technologies in clinical trials to streamline data collection and speed up insight-driven analysis via machine learning and more to accelerate trial timelines and improve the patient experience and safety.
- How to create opportunities for faster drug development through solutions such as decentralized trials, wearables, remote monitoring and more.
- Denise Messer, director of Design Analytics at IQVIA, chaired the “Approaching the Assessment of Clinical Protocol Complexity” session today, and provided insights into the importance of data integrity in addressing protocol complexity. Sharing case study findings and more, Denise and Zachary Smith, a data scientist with the Tufts Center for the Study of Drug Development, showed how key data sources commonly used to support protocol complexity tools, analyses and scoring often lack data integrity, which is beneficial to help study teams create benchmarks for protocol complexity and to determine trial design elements that may negatively impact performance.
- At the “FDA Real-World Evidence Guidance for Regulatory Approval: Implications for Evidence Needs for Payers and Population-Based Decision Makers and Healthcare Providers” forum, IQVIA’s Vice President of Real World Evidence Matthew Reynolds joined various industry experts to discuss what each found necessary to ensure real-world data (RWD) using in generating real-world evidence (RWE) meets the new draft U.S. Food and Drug Administration (FDA) guidance recommendations. Panelists emphasized what pharmaceutical companies and data providers need to do to implement these requirements and how it will impact how to communicate RWE to payers and healthcare providers.
- In another forum regarding RWD and RWE titled, “Post-Approval Safety Studies: Approaches to Assessing Medication Exposure and Potential Safety Risks During Pregnancy,” Senior Principal of Real World Strategy and Innovation at IQVIA Lockwood Taylor joined global regulatory and pharmaceutical industry experts to shed light on how RWD and related evidence from claims and electronic health record databases may help address some of the long-standing challenges in collecting pregnancy safety information in a post-marketing setting via registries and in evaluating drug safety during pregnancy.
Wrapping up another jam-packed day at DIA 2022, we hope we provided some insightful food for thought in terms of innovative approaches to tackling some of the industry’s ongoing challenges to successful drug development in a complex environment.
We’ve got several days of DIA left with many exciting activities and conversations to have with fellow attendees to ensure we’re making progress in our collective efforts to advance human health.
For DIA 2022 attendees and others interested in connecting with IQVIA leadership to learn more about our services and to come try out our various solutions’ demo stations, please visit us at the IQVIA booth (#1300), IQVIA Laboratories booth (#1209) or contact us here.
We’ll see you tomorrow with more daily highlights from DIA 2022!